Government News

The Ministry of Health and Family Welfare has issued an advisory to States and Union Territories regarding the regulation of stem cell therapy, reiterating that stem cell treatments can be offered as standard clinical care only for approved disease conditions and indications. The advisory was issued on September 16, 2026, in the context of the Supreme Court judgment dated January 30, 2026, in Yash Charitable Trust & Ors. v. Union of India & Ors.

The Central Drugs Standard Control Organization (CDSCO) has cancelled three registration certificates issued to M/s Skintl Enterprises Pvt. Ltd., citing multiple violations related to the import, labelling and handling of cosmetic products. The cancellation order was issued by the Central Licensing Authority on 24 August 2026.

The Central Drugs Standard Control Organization (CDSCO) has released its July 2026 Not of Standard Quality (NSQ) drug alert, listing a large number of medicine samples that failed to meet specified quality standards during testing by state and CDSCO laboratories.

The Pharmacy Council of India (PCI) has introduced four major initiatives aimed at strengthening pharmacy education, research and professional development in India. The initiatives were unveiled at CAPSULE 4.0 and include the new M.Pharm (Medical Devices) programme, Research Promotion Scheme (RPS), Doctoral Fellowship Scheme (PDFS) and Pharmacy Awards.

The Central Drugs Standard Control Organisation (CDSCO) has clarified that applications seeking permission to import and market new drugs that are not approved anywhere in the world, where Phase III Global Clinical Trials (GCTs) are either ongoing or have been completed with the participation of Indian subjects, will be examined and processed by the Investigational New Drug (IND) Division.